These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9832215)

  • 1. Effect of selective inhibition of cyclooxygenase 2 on temporary focal cerebral ischemia in rats.
    Hara K; Kong DL; Sharp FR; Weinstein PR
    Neurosci Lett; 1998 Oct; 256(1):53-6. PubMed ID: 9832215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
    Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ
    J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and vascular effects of cyclooxygenase-2 in brain.
    Brian JE; Moore SA; Faraci FM
    Stroke; 1998 Dec; 29(12):2600-6. PubMed ID: 9836773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cyclooxygenase-2 inhibitor NS-398 ameliorates ischemic brain injury in wild-type mice but not in mice with deletion of the inducible nitric oxide synthase gene.
    Nagayama M; Niwa K; Nagayama T; Ross ME; Iadecola C
    J Cereb Blood Flow Metab; 1999 Nov; 19(11):1213-9. PubMed ID: 10566967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic cyclooxygenase-2 inhibition blunts low sodium-stimulated renin without changing renal haemodynamics.
    Harding P; Carretero OA; Beierwaltes WH
    J Hypertens; 2000 Aug; 18(8):1107-13. PubMed ID: 10954003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A structural feature of N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulfonamide (NS-398) that governs its selectivity and affinity for cyclooxygenase 2 (COX2).
    Huff R; Collins P; Kramer S; Seibert K; Koboldt C; Gregory S; Isakson P
    Inflamm Res; 1995 Aug; 44 Suppl 2():S145-6. PubMed ID: 8548370
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of selective cyclooxygenase-2 inhibitor on corneal angiogenesis in the rat.
    Yamada M; Kawai M; Kawai Y; Mashima Y
    Curr Eye Res; 1999 Oct; 19(4):300-4. PubMed ID: 10520225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducible cyclooxygenase-2 expression after experimental intracerebral hemorrhage.
    Gong C; Ennis SR; Hoff JT; Keep RF
    Brain Res; 2001 May; 901(1-2):38-46. PubMed ID: 11368948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed effect of administration of COX-2 inhibitor in mice with acute cerebral ischemia.
    Sugimoto K; Iadecola C
    Brain Res; 2003 Jan; 960(1-2):273-6. PubMed ID: 12505683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of prostaglandins generated by cyclooxygenase-1 and cyclooxygenase-2 in healing of ischemia-reperfusion-induced gastric lesions.
    Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Drozdowicz D; Stachura J; Pajdo R; Hahn EG
    Eur J Pharmacol; 1999 Nov; 385(1):47-61. PubMed ID: 10594344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of cyclooxygenase-2 (COX-2) reduces prostaglandin E2 production and attenuates systemic disease sequelae in experimental pancreatitis.
    Foitzik T; Hotz HG; Hotz B; Wittig F; Buhr HJ
    Hepatogastroenterology; 2003; 50(52):1159-62. PubMed ID: 12846004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of cyclooxygenase-2 accounts for restraint stress-induced oxidative status in rat brain.
    Madrigal JL; Moro MA; Lizasoain I; Lorenzo P; Fernández AP; Rodrigo J; Boscá L; Leza JC
    Neuropsychopharmacology; 2003 Sep; 28(9):1579-88. PubMed ID: 12784118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase-1 mediates the final stage of morphine-induced delayed cardioprotection in concert with cyclooxygenase-2.
    Jiang X; Shi E; Nakajima Y; Sato S; Ohno K; Yue H
    J Am Coll Cardiol; 2005 May; 45(10):1707-15. PubMed ID: 15893191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the relative contribution of COX-1 and COX-2 isoforms to ischemia-induced oxidative damage and neurodegeneration following transient global cerebral ischemia.
    Candelario-Jalil E; González-Falcón A; García-Cabrera M; Alvarez D; Al-Dalain S; Martínez G; León OS; Springer JE
    J Neurochem; 2003 Aug; 86(3):545-55. PubMed ID: 12859668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 inhibitor ns-398 protects neuronal cultures from lipopolysaccharide-induced neurotoxicity.
    Araki E; Forster C; Dubinsky JM; Ross ME; Iadecola C
    Stroke; 2001 Oct; 32(10):2370-5. PubMed ID: 11588328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of ethanol on the expression of cyclo-oxygenase in cultured cortical astrocytes and neurons.
    Luo J; Lindström CL; Donahue A; Miller MW
    J Neurochem; 2001 Mar; 76(5):1354-63. PubMed ID: 11238720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of cyclooxygenase-2 on formation and healing of acetic acid-induced gastric ulcer in rats].
    Shen X
    Zhonghua Yi Xue Za Zhi; 2001 Nov; 81(22):1380-3. PubMed ID: 11930633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cyclooxygenase-2 by NS-398 following hemorrhage and subsequent sepsis: no beneficial effects in either gender.
    Kahlke V; Seidel M; Stapela S; Brötzmann K; Schafmayer C; Schröder J
    Surg Infect (Larchmt); 2004; 5(1):29-37. PubMed ID: 15142421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of pathological and behavioral deficits following spinal cord contusion injury with the selective cyclooxygenase-2 inhibitor NS-398.
    Hains BC; Yucra JA; Hulsebosch CE
    J Neurotrauma; 2001 Apr; 18(4):409-23. PubMed ID: 11336442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential inhibition by nimesulide of the early and late phases of intravenous- and intracerebroventricular-LPS-induced fever in guinea pigs.
    Steiner AA; Li S; Llanos-Q J; Blatteis CM
    Neuroimmunomodulation; 2001; 9(5):263-75. PubMed ID: 11964521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.